Piper Sandler on Bristol-Myers Squibb Co. (BMY): 'Milvexian Did Strike Us As High-Risk'
Go back to Piper Sandler on Bristol-Myers Squibb Co. (BMY): 'Milvexian Did Strike Us As High-Risk'| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 64.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.65 | 52 Week High | $77.12 | |||
| Open | $64.65 | 52 Week Low | $49.03 | |||
| Day High | $64.65 | P/E | 41.98 | |||
| Day Low | $64.65 | EPS | $1.54 | |||
| Volume | 959 | |||||
